These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15910568)

  • 1. Surgical treatment of patients with refractory migraine headaches and intranasal contact points.
    Behin F; Behin B; Bigal ME; Lipton RB
    Cephalalgia; 2005 Jun; 25(6):439-43. PubMed ID: 15910568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endonasal surgery for contact point headaches: a 10-year longitudinal study.
    Welge-Luessen A; Hauser R; Schmid N; Kappos L; Probst R
    Laryngoscope; 2003 Dec; 113(12):2151-6. PubMed ID: 14660919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3-year follow-up after endonasal microscopic paranasal sinus surgery in migraine and cluster headache].
    Welge-Lüssen A; Hauser R; Probst R
    Laryngorhinootologie; 1996 Jul; 75(7):392-6. PubMed ID: 8924166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhinologic evaluation in patients with primary headache.
    Yazici ZM; Cabalar M; Sayin I; Kayhan FT; Gurer E; Yayla V
    J Craniofac Surg; 2010 Nov; 21(6):1688-91. PubMed ID: 21119401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of sinus headache as migraine: the diagnostic utility of triptans.
    Kari E; DelGaudio JM
    Laryngoscope; 2008 Dec; 118(12):2235-9. PubMed ID: 18948830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Headache prevention outcome and body mass index.
    Bigal ME; Gironda M; Tepper SJ; Feleppa M; Rapoport AM; Sheftell FD; Lipton RB
    Cephalalgia; 2006 Apr; 26(4):445-50. PubMed ID: 16556246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occipital nerve stimulation for chronic headache--long-term safety and efficacy.
    Schwedt TJ; Dodick DW; Hentz J; Trentman TL; Zimmerman RS
    Cephalalgia; 2007 Feb; 27(2):153-7. PubMed ID: 17257236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive/tertiary care for headache: a 6-month outcome study.
    Saper JR; Lake AE; Madden SF; Kreeger C
    Headache; 1999 Apr; 39(4):249-63. PubMed ID: 15613222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.
    Tepper SJ; Bigal ME; Sheftell FD; Rapoport AM
    Headache; 2004 Sep; 44(8):794-800. PubMed ID: 15330826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sinus, Allergy and Migraine Study (SAMS).
    Eross E; Dodick D; Eross M
    Headache; 2007 Feb; 47(2):213-24. PubMed ID: 17300361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine changes with age: IMPACT on migraine classification.
    Kelman L
    Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of migraine after a 10-year follow-up.
    Nachit-Ouinekh F; Dartigues JF; Chrysostome V; Henry P; Sourgen C; El Hasnaoui A
    Headache; 2005; 45(10):1280-7. PubMed ID: 16324159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of an intensive multidisciplinary headache treatment program.
    Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
    Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disability and quality of life in different primary headaches: results from Italian studies.
    Bussone G; Usai S; Grazzi L; Rigamonti A; Solari A; D'Amico D
    Neurol Sci; 2004 Oct; 25 Suppl 3():S105-7. PubMed ID: 15549514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR; Smith SW; Moore J; Biros M
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.